









Markets
/
Stocks
/
nasdaq-rapp
/

Rapport Therapeutics Inc

RAPP

27.840USD

-1.160-4.00%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

984.88MMarket Cap

LossP/E TTM



Rapport Therapeutics Inc

27.840

-1.160-4.00%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Rapport Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

Total equity

Cash, cash equivalents and short-term investments

60.68%490.54M

59.99%513.03M

-22.52%260.45M

47.68%285.38M

--305.28M

--320.66M

--336.14M

--193.24M

- Cash and cash equivalents

-7.32%52.65M

539.36%251.36M

-50.01%55.07M

-22.44%57.60M

--56.80M

--39.31M

--110.16M

--74.27M

-Short-term investments

76.23%437.89M

-6.99%261.67M

-9.11%205.38M

91.45%227.78M

--248.47M

--281.35M

--225.97M

--118.98M

Prepaid expenses

79.24%7.92M

45.52%7.53M

119.13%9.69M

1.90%5.48M

--4.42M

--5.17M

--4.42M

--5.38M

Other current assets

0.00%105.00K

--105.00K

Total current assets

60.93%498.56M

59.74%520.66M

-20.67%270.24M

46.42%290.97M

--309.80M

--325.94M

--340.67M

--198.73M

Non-current assets

Net Fixed Assets

159.20%12.88M

171.05%13.60M

171.20%14.22M

98.14%10.87M

--4.97M

--5.02M

--5.24M

--5.49M

-Fixed Assets

150.45%14.87M

167.68%15.31M

173.78%15.68M

109.54%12.08M

--5.94M

--5.72M

--5.73M

--5.77M

-Accumulated depreciation

105.39%1.98M

143.69%1.72M

201.65%1.46M

333.69%1.21M

--965.00K

--705.00K

--485.00K

--279.00K

Other non-current assets

515.63%985.00K

465.08%1.07M

447.09%1.03M

-89.82%211.00K

--160.00K

--189.00K

--2.07M

Total non-current assets

170.32%13.87M

181.73%14.66M

180.80%15.25M

46.61%11.09M

--5.13M

--5.21M

--5.43M

--7.56M

Total assets

62.71%512.43M

61.66%535.32M

-17.51%285.50M

46.42%302.05M

--314.93M

--331.14M

--346.10M

--206.29M

Liabilities

Current liabilities

-Other payables

162.14%4.98M

123.51%3.46M

8.64%3.73M

-41.68%3.81M

--1.90M

--1.55M

--3.44M

--6.54M

Accrued expenses

70.60%7.13M

46.49%5.14M

54.30%3.21M

100.00%2.42M

--4.18M

--3.51M

--2.08M

--1.21M

Other current liabilities

162.14%4.98M

123.51%3.46M

8.64%3.73M

-41.68%3.81M

--1.90M

--1.55M

--3.44M

--6.54M

Total current liabilities

117.28%19.05M

101.66%14.32M

46.74%11.88M

-5.08%9.38M

--8.77M

--7.10M

--8.10M

--9.88M

Non-current liabilities

Long-term debt and lease liabilities

1081.19%8.73M

908.59%9.39M

804.57%10.10M

426.50%6.83M

--739.00K

--931.00K

--1.12M

--1.30M

-Long-term lease liabilities

1081.19%8.73M

908.59%9.39M

804.57%10.10M

426.50%6.83M

--739.00K

--931.00K

--1.12M

--1.30M

Other non-current liabilities

--0.00

----

--0.00

----

Total non-current liabilities

1081.19%8.73M

908.59%9.39M

804.57%10.10M

426.50%6.83M

--739.00K

--931.00K

--1.12M

--1.30M

Total liabilities

192.22%27.78M

195.22%23.71M

138.63%21.98M

45.01%16.22M

--9.51M

--8.03M

--9.21M

--11.18M

Shareholders' equity

Common equity

67.41%719.34M

67.17%712.94M

3.50%438.13M

1414.77%433.74M

--429.69M

--426.48M

--423.30M

--28.63M

Retained earnings

-90.09%-235.23M

-94.16%-201.47M

-102.42%-174.54M

-117.02%-147.81M

---123.75M

---103.77M

---86.23M

---68.11M

Capital reserves

67.41%719.29M

67.17%712.89M

3.50%438.09M

1414.85%433.70M

--429.66M

--426.44M

--423.26M

--28.63M

Gains losses not affecting retained earnings

204.60%546.00K

-63.75%145.00K

58.47%-76.00K

40.63%-95.00K

---522.00K

--400.00K

---183.00K

---160.00K

Total equity

58.68%484.65M

58.34%511.62M

-21.78%263.51M

46.50%285.84M

--305.43M

--323.11M

--336.89M

--195.11M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

